Department of Anaesthesiology, UZ Leuven, Leuven, Belgium; Department of Cardiovascular Sciences, Group Biomedical Sciences, KU Leuven, Leuven, Belgium.
Department of Obstetrics and Gynaecology, UZ Leuven, Leuven, Belgium; Department of Development and Regeneration, Cluster Woman and Child, Group Biomedical Sciences, KU Leuven, Leuven, Belgium.
Br J Anaesth. 2021 Jun;126(6):1128-1140. doi: 10.1016/j.bja.2021.02.026. Epub 2021 Apr 6.
The US Food and Drug Administration warned that exposure of pregnant women to general anaesthetics may impair fetal brain development. This review systematically evaluates the evidence underlying this warning.
PubMed, EMBASE, and Web of Science were searched from inception until April 3, 2020. Preclinical and clinical studies were eligible. Exclusion criteria included case reports, in vitro models, chronic exposures, and exposure only during delivery. Meta-analyses were performed on standardised mean differences. The primary outcome was overall effect on learning/memory. Secondary outcomes included markers of neuronal injury (apoptosis, synapse formation, neurone density, and proliferation) and subgroup analyses.
There were 65 preclinical studies included, whereas no clinical studies could be identified. Anaesthesia during pregnancy impaired learning and memory (standardised mean difference -1.16, 95% confidence interval -1.46 to -0.85) and resulted in neuronal injury in all experimental models, irrespective of the anaesthetic drugs and timing in pregnancy. Risk of bias was high in most studies. Rodents were the most frequently used animal species, although their brain development differs significantly from that in humans. In a minority of studies, anaesthesia was combined with surgery. Monitoring and strict control of physiological homeostasis were below preclinical and clinical standards in many studies. The duration and frequency of exposure and anaesthetic doses were often much higher than in clinical routine.
Anaesthesia-induced neurotoxicity during pregnancy is a consistent finding in preclinical studies, but translation of these results to the clinical situation is limited by several factors. Clinical observational studies are needed.
CRD42018115194.
美国食品和药物管理局警告称,孕妇接触全身麻醉剂可能会损害胎儿大脑发育。本综述系统评估了这一警告背后的证据。
从建库到 2020 年 4 月 3 日,我们检索了 PubMed、EMBASE 和 Web of Science。合格的研究包括临床前和临床研究。排除标准包括病例报告、体外模型、慢性暴露以及仅在分娩时暴露。对标准化均数差进行了荟萃分析。主要结局是学习/记忆的总体影响。次要结局包括神经元损伤标志物(细胞凋亡、突触形成、神经元密度和增殖)和亚组分析。
共纳入 65 项临床前研究,未发现临床研究。妊娠期间的麻醉会损害学习和记忆(标准化均数差-1.16,95%置信区间-1.46 至-0.85),并且在所有实验模型中都会导致神经元损伤,无论使用何种麻醉药物以及妊娠时间如何。大多数研究的偏倚风险较高。啮齿类动物是最常使用的动物物种,尽管它们的大脑发育与人类有很大的不同。在少数研究中,麻醉与手术相结合。在许多研究中,监测和严格控制生理稳态都低于临床前和临床标准。暴露的持续时间和频率以及麻醉剂量往往远高于临床常规。
在临床前研究中,麻醉诱导的妊娠期神经毒性是一个一致的发现,但这些结果向临床情况的转化受到几个因素的限制。需要进行临床观察性研究。
PROSPERO 注册号:CRD42018115194。